NEW YORK -- As the new coronavirus spreads in the U.S., health officials are warning of resource strains on several fronts, such as having just 10% of the N-95 masks needed by medical professionals in a full-blown outbreak, as well as potential drug shortages.
Following supply chain disruptions in China, India on Tuesday announced export controls on 26 active drug ingredients -- mostly antibiotics -- alarming the U.S. Food and Drug Administration. FDA chief Stephen Hahn told lawmakers at a Senate hearing that the agency is still going through the list to determine how much effect the controls will have on the country's medical supply chain.
